*Refresh the page if the below document does not appear.
The french drugmaker Sanofi in its forecast said that it is now expecting faster earnings growth this financial year on account of strong demand for its bestselling drug ‘Dupixent’ and for its flu vaccines.
The AHF (AIDS Healthcare Foundation) group caregivers hit out at the California-based Drugmaker Gilead Sciences and accused them of being ‘Greediad’ as they refused to offer the 340B discount price for HIV drugs to providers who use contract pharmacies.
The Multi-Disciplinary Committee (MDC) of experts, which is the advisory committee to NPPA (National Pharmaceutical Pricing Authority) recently has taken the step of fixing the retail price of anti-Diabetes drug combination comprising of sitagliptin and dapagliflozin.
Since, there is a large number of drugs going off-patent in the next 10 years including Biologics which are high-value products. If interested in Biosimilars, this is the right time for Indian Pharma companies to invest in the R&D if they wish to make proper use of the opportunities.
GSK announced that it would not be moving forward with the regulatory submissions of its experimental drug after it failed to meet a key goal in a late-stage study. The drug named “otilimab” was indicated for the treatment of moderate-to-severe Rheumatoid Arthritis (RA).
The US regulatory authority conducted a priorapproved inspection of Lupin’s biotech manufacturing facility in Pune earlier this month and issued a form 483 with 17 observations. The company said in a statement that it won’t be having any effect on the revenue generated by the operations of the unit.
On Thursday, a large international study
announced that AstraZeneca’s COVID-19
vaccine has been linked to 30% higher risk of
getting a very rare blood-clotting condition
when compared to the Pfizer COVID-19
If you don’t already have an account click the button below to create your account.Create New Account